Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:163-167
Published online before print November 25, 2002, doi: 10.1161/01.HYP.0000043680.75107.CF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/1/163    most recent
01.HYP.0000043680.75107.CFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jin, J. J.
Right arrow Articles by Miki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jin, J. J.
Right arrow Articles by Miki, T.
Related Collections
Right arrow Clinical genetics

(Hypertension. 2003;41:163.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Association of Endothelin-1 Gene Variant With Hypertension

Jing Ji Jin; Jun Nakura; Zhihong Wu; Miyuki Yamamoto; Michiko Abe; Yasuharu Tabara; Yoshikuni Yamamoto; Michiya Igase; Katsuhiko Kohara; Tetsuro Miki

From the Department of Geriatric Medicine, School of Medicine, Ehime University, Ehime, Japan.

Correspondence to Dr Jun Nakura, Department of Geriatric Medicine, School of Medicine, Ehime University, Shigenobu-cho, Onsen-gun, Ehime 791-0295, Japan. E-mail nakura{at}m.ehime-u.ac.jp

Endothelin-1 (ET-1) is a powerful vasoconstrictor peptide produced by endothelial and smooth muscle cells. Many lines of biological evidence suggest that the ET-1 gene is a candidate gene for hypertension. Moreover, recent association studies suggested that a G/T polymorphism with an amino acid substitution (Lys/Asn) at codon 198 in exon 5 of the ET-1 gene interacts with body mass index (BMI) in association with blood pressure. They suggested that T carriers are more sensitive to weight gain than GG homozygotes in association with blood pressure. However, association studies are often irreproducible, and the first study often suggests a stronger genetic effect than is found by subsequent studies. We therefore assessed the interaction in 2 large Japanese populations. The present study showed a nonsignificant but similar trend to the results of previous reports. Moreover, in line with previous reports, this study revealed a significant interaction between the ET-1 K198N (G/T) polymorphism and BMI in association with hypertension in our populations (P=0.027). The interaction was significant, even after adjustment for gender and age (P=0.045) and for all confounding factors (P=0.044). T carriers were more sensitive to weight gain than GG homozygotes in association with hypertension. Considering the combined impact of obesity and hypertension on the development of cardiovascular and cerebrovascular disorders, T allele carriers might represent elective targets for therapy to lower their body weight.


Key Words: endothelin • hypertension, essential • genetics • polymorphism • body mass index




This article has been cited by other articles:


Home page
HypertensionHome page
T. Rankinen, T. Church, T. Rice, N. Markward, A. S. Leon, D. C. Rao, J. S. Skinner, S. N. Blair, and C. Bouchard
Effect of Endothelin 1 Genotype on Blood Pressure Is Dependent on Physical Activity or Fitness Levels
Hypertension, December 1, 2007; 50(6): 1120 - 1125.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al.
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation, June 5, 2007; 115(22): 2878 - 2901.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
E. Thomson, P. Kumarathasan, P. Goegan, R. A. Aubin, and R. Vincent
Differential Regulation of the Lung Endothelin System by Urban Particulate Matter and Ozone
Toxicol. Sci., November 1, 2005; 88(1): 103 - 113.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Dong, X. Wang, H. Zhu, F. A. Treiber, and H. Snieder
Endothelin-1 Gene and Progression of Blood Pressure and Left Ventricular Mass: Longitudinal Findings in Youth
Hypertension, December 1, 2004; 44(6): 884 - 890.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Diefenbach, F. A. Nahad, C. Meisel, I. Fietze, I. Cascorbi, K. Stangl, O. Landt, R. Kerb, U. Brinkmann, and I. Roots
Identification of Twelve Polymorphisms in the Endothelin-1 Gene by Use of Fluorescently Labeled Oligonucleotides and PCR with Restriction Fragment Polymorphism Analysis
Clin. Chem., February 1, 2004; 50(2): 448 - 451.
[Full Text] [PDF]


Home page
HypertensionHome page
C. Cardillo, U. Campia, M. Iantorno, and J. A. Panza
Enhanced Vascular Activity of Endogenous Endothelin-1 in Obese Hypertensive Patients
Hypertension, January 1, 2004; 43(1): 36 - 40.
[Abstract] [Full Text] [PDF]